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Abstract The effect of the myotoxic drug chlorpromazine was 
studied in vitro on proteins of sarcoplasmic reticulum and mito- 
chondrial matrix of skeletal muscle in the normal mouse. Our 
results indicate that the drug is specific for calcium-binding pro- 
teins (calcium ATPase, calsequestrin and calmitine). Its prote- 
olytic effect on these proteins, apparently due to the stimulation 
of specific proteases, could account for its myotoxic action. 
Moreover, calsequestrin (sarcoplasmic reticulum) and calmitine 
(mitoehondrial matrix) were not sensitive to the same proteases. 
Proteases acting on caimitine were inhibited by a2-macroglobulin 
but not those acting on calsequestrin. Despite some similarities 
between these two proteins, their characteristics of localization 
and sensitivity of their proteases indicate that calmitine has a 
specificity within the mitochondrial matrix and very probably 
plays a major role in the mitochondrial regulation of free calcium, 
which controls the activity of various enzymes of the mitochon- 
drial matrix involved in ATP synthesis. 
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calcium in response to cellular demand. This could account in 
part for muscle degeneration i  patients with Duchenne's or 
Becker's muscular dystrophy and in dy/dy mice for which a 
large calmitine deficit has been observed [9]. Moreover, an 
experimental calmitine deficit, associated with increased mito- 
chondrial free calcium and muscle degeneration, has been ob- 
tained in the normal mouse after a single injection of the 
myotoxic drug chlorpromazine [10]. According to data in the 
literature, this drug has an affinity for calcium-binding proteins 
[11,12] and could act more specifically at the mitochondrial 
level [13]. We studied the effect of chlorpromazine in v tro on 
subcellular fractions (sarcoplasmic reticulum and mitochon- 
drial matrix) to determine whether the proteolytic action ob- 
served in vivo on calmitine was the same for other calcium- 
bound proteins (calcium ATPase and calsequestrin) or whether 
calmitine in fact showed particularities differentiating it from 
calsequestrin a d according ita role and a very specific function 
within the mitochondrial matrix. 
I. Introduction 
Calmitine, a mitochondrial calcium-binding protein specific 
for fast skeletal muscle [1], shows some similarities with calse- 
questrin [2]. The fact that it has recently been localized more 
specifically in the mitochondrial matrix [2] suggests hat it plays 
a primordial role in the regulation of mitochondrial bound and 
free calcium [3] and thus in the cellular functioning and partic- 
ularly the synthesis of ATE There is increasing evidence that 
mitochondrial calcium, which influences the activity of various 
matrical enzymes involved in oxidative phosphorylation and 
the production of cellular energy, plays a second messenger role 
triggering mitochondrial response to cytosolic signals [4]. For 
example, at the time of muscle contraction, when the need for 
ATP is very great, the concentration f cytosolic alcium (re- 
leased by sarcoplasmic reticulum) increases, producing an aug- 
mentation of mitochondrial calcium serving to stimulate the 
activity of certain matrical enzymes (dehydrogenases [5 7], 
ATP synthase [8]) responsible for ATP production. It is note- 
worthy that calcium is the only known second messenger capa- 
ble of entering mitochondria. The concentration f free calcium 
in the mitochondrial matrix influences certain enzymes of the 
electron transport chain. Calmitine, by binding calcium, could 
regulate the mitochondrial balance between free and bound 
*Corresponding author. Fax: (33) (40) 403686. 
2. Experimental 
2.1. Subcellular J actioning 
Fractions of sarcoplasmic reticulum andmitochondria from gas- 
trocnemius muscle of Swiss mice were obtained as previously described 
[14]. The preparation f mitochondrial matrix from isolated mitochon- 
dria was performed as reported in [15]. Pure calmitine was obtained by 
electroelution f matrical calmitine. The protein concentration of he 
fractions was determined by the method of Lowry [16]. 
2.2. Incubation of subcellular fractions and protein separation 
Fractions of sarcoplasmic reticulum, mitochondrial matrix and elu- 
ate collected in MOPS-KC1 (10% triton X 100) buffer were incubated 
for 0.5 to 10 min at 37°C or4°C in the presence or absence of chlorpro- 
mazine (5 mg/mg of protein) and ~2 macroglobuline (2 mg/mg of 
protein). The proteins of the different fractions were then separated in 
duplicate by SDS polyacrylamide g lelectrophoresis [17]. One gel was 
stained with Coomassie brilliant blue, and the other was used for 
blotting on nitrocellulose. Ca 45 binding was performed on blots, as 
described in [18]. 
3. Results and discussion 
Chlorpromazine, a phenothiazine derivative, is a myotoxic 
drug in vivo which seems more specifically to have a degenera- 
tive action on mitochondria [13] and a preferential effect on 
calcium-binding proteins [11,12]. During a previous tudy [10], 
we found that a single intramuscular injection of chlorpromaz- 
ine in the normal mouse caused a decrease in mitochondrial 
calmitine associated with an increase in mitochondrial free cal- 
cium and a degeneration f muscle fibers. The in vitro results 
reported here confirm this specific effect of chlorpromazine on
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calcium-binding proteins and provide a possible explanation 
for its mechanism of action. 
Fig. 1 (A and B) shows that the drug caused nearly total 
degradation of calcium ATPase and calsequestrin i  sarcoplas- 
mic reticulum (Fig. 1A), and of calmitine in the mitochondrial 
matrix fraction (Fig. 1B). It can be seen that the proteolysis 
increased as  function of time. Conversely, calmitine obtained 
by electroelution of the matrical protein showed no degra- 
dation as a result of chlorpromazine action (Fig. 2A, lanes 7 
and 8). 
It is very likely that the lack of any effect of chlorpromazine 
on eluted calmitine means that the drug acts through enzymes 
isolated respectively in sarcoplasmic reticulum and mitochon- 
drial matrix and totally absent in the eluate (owing to the way 
in which it was obtained). Chlorpromazine would appear to 
stimulate the specific proteases of these proteins. Our results 
(Fig. 2) indicate that the proteolytic activity of chlorpromazine 
on calmitine was abolished in the mitochondrial matrix fraction 
in the presence of the protease inhibitor ~2-macroglobulin. 
Conversely, ~2-macroglobulin did not prevent he proteolytic 
activity of chlorpromazine on the calcium ATPase and calse- 
questrin of sarcoplasmic reticulum (Fig. 2). These observations, 
clearly showing that calsequestrin a d calmitine, despite certain 
similarities [2], are not dependent o  he same protease, suggest 
that each has a distinct specificity in addition to a different 
localization. It may be noted that in all cases Ca 45 binding to 
specific proteins (Fig. 2B) reflected the quantitative protein 
variations observed after Coomassie brilliant blue staining 
(Fig. 2A). 
In vitro and in vivo experiments were performed by replacing 
chlorpromazine with phenothiazine which had no proteolytic 
effect on the proteins tudied. Thus, the specific effect found 
in our study is attributable only to the derivative chlorpromaz- 
ine. (This drug may unblock calmitine synthesis in genetically 
dystrophic mouse [19]). We also tested another myotoxic drug, 
metoclopramide, which had no proteolytic effect on the pro- 
teins studied. 
Thus, our study shows that the myotoxic effect of chlorpro- 
mazine could be due to a stimulation of the specific proteases 
of calcium-binding proteins (calcium ATPase, calsequestrin 
and calmitine). These proteins play a primordial role in muscu- 
lar function, and their degradation could lead to muscle degen- 
eration. Despite their similarities, calsequestrin and calmitine 
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Fig. 1. Separation of subcellular fraction proteins by SDS poly- 
acrylamide gel electrophoresis and Coomassie brillant blue staining. 
(A) Sarcoplasmic reticulum fractions (40 pg) were incubated for 30 sec 
(lane 1), 1 min (lane 2), 5 rain (lane 3), in the presence of chlorpromaz- 
ine; lane 0: control without chlorpromazine. (B) Mitochondrial matrix 
fractions (30 pg) were incubated for 30 s (lane 1), 1 min (lane 2) and 
5 rain (lane 3)in the presence of chlorpromazine; lane 0: control without 
chlorpromazine. 
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Fig. 2. Separation of subcellular fraction proteins by SDS poly- 
acrylamide gel electrophoresis. All fractions were incubated for 10 min 
in the presence or absence of chlorpromazine and ~2 macroglobulin. 
lanes 1 3: sarcoplasmic reticulum (60/~g): lane 1, control; lane 2: with 
chlorpromazine; lane 3: with chlorpromazine and ~2 macroglobuline. 
Lanes 4~6: mitochondrial matrix (30/lg): lane 4: control; lane 5: with 
chlorpromazine; lane 6: with chlorpromazine and ~2 macroglobuline. 
Lanes 7 and 8: eluated calmitine (10/lg): lane 7 control; lane 8 with 
chlorpromazine. (A) Coomassie brilliant blue staining. (B) 45Ca binding 
proteins after autoradiography. 
have different localizations (respectively sarcoplasmic reticu- 
lum and mitochondrial matrix) and do not respond to the same 
proteolytic enzymes. The proteases of calsequestrin are insensi- 
tive to ~2-macroglobulin, whereas those of calmitine are not. 
These observations eem to indicate a real specificity of 
calmitine within the mitochondrial matrix of skeletal muscle. 
The role of calmitine could thus prove of considerable impor- 
tance in mitochondrial response to cellular energy demands. 
Calmitine, as a function of cellular ATP needs, would continu- 
ally adapt he balance between free and bound calcium within 
the mitochondrial matrix, either activating or inhibiting (as 
circumstances required) the matrical enzymes involved in ATP 
synthesis. 
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